286 related articles for article (PubMed ID: 35975761)
21. Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants.
Gould TD; Zarate CA; Thompson SM
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():213-236. PubMed ID: 30296896
[TBL] [Abstract][Full Text] [Related]
22. The mechanistic basis for the rapid antidepressant-like effects of ketamine: From neural circuits to molecular pathways.
Ren L
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110910. PubMed ID: 38061484
[TBL] [Abstract][Full Text] [Related]
23. [A review of the antidepressant properties of ketamine].
Desfossés CY; Blier P
Med Sci (Paris); 2021 Jan; 37(1):27-34. PubMed ID: 33492215
[TBL] [Abstract][Full Text] [Related]
24. Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.
Gerhard DM; Wohleb ES; Duman RS
Drug Discov Today; 2016 Mar; 21(3):454-64. PubMed ID: 26854424
[TBL] [Abstract][Full Text] [Related]
25. The role of mGlu
Pałucha-Poniewiera A
Pharmacol Biochem Behav; 2022 Oct; 220():173454. PubMed ID: 36038006
[TBL] [Abstract][Full Text] [Related]
26. mGlu2/3 receptor as a novel target for rapid acting antidepressants.
Chaki S
Adv Pharmacol; 2020; 89():289-309. PubMed ID: 32616210
[TBL] [Abstract][Full Text] [Related]
27. Rapid onset brain plasticity at novel pharmacologic targets hypothetically drives innovations for rapid onset antidepressant actions.
Cooper T; Seigler MD; Stahl S
J Psychopharmacol; 2023 Mar; 37(3):242-247. PubMed ID: 36988262
[TBL] [Abstract][Full Text] [Related]
28. Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine.
López-Gil X; Jiménez-Sánchez L; Campa L; Castro E; Frago C; Adell A
ACS Chem Neurosci; 2019 Jul; 10(7):3318-3326. PubMed ID: 31244055
[TBL] [Abstract][Full Text] [Related]
29. A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.
Savalia NK; Shao LX; Kwan AC
Trends Neurosci; 2021 Apr; 44(4):260-275. PubMed ID: 33358035
[TBL] [Abstract][Full Text] [Related]
30. The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.
Monteggia LM; Gideons E; Kavalali ET
Biol Psychiatry; 2013 Jun; 73(12):1199-203. PubMed ID: 23062356
[TBL] [Abstract][Full Text] [Related]
31. The rapid-onset antidepressant effect of ketamine: More surprises?
Raffa RB; Pergolizzi JV; Taylor R;
J Clin Pharm Ther; 2018 Apr; 43(2):308-311. PubMed ID: 29178131
[TBL] [Abstract][Full Text] [Related]
32. mGlu2/3 receptor antagonism: A mechanism to induce rapid antidepressant effects without ketamine-associated side-effects.
Witkin JM
Pharmacol Biochem Behav; 2020 Mar; 190():172854. PubMed ID: 31954773
[TBL] [Abstract][Full Text] [Related]
33. Ketamine and other potential glutamate antidepressants.
Dutta A; McKie S; Deakin JFW
Psychiatry Res; 2015 Jan; 225(1-2):1-13. PubMed ID: 25467702
[TBL] [Abstract][Full Text] [Related]
34. Ketamine for Treatment-Resistant Depression: a New Advocate.
Pérez-Esparza R
Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013
[TBL] [Abstract][Full Text] [Related]
35. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
[TBL] [Abstract][Full Text] [Related]
36. [Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?].
Bottemanne H; Claret A; Fossati P
Encephale; 2021 Apr; 47(2):171-178. PubMed ID: 33190819
[TBL] [Abstract][Full Text] [Related]
37. Novel therapeutic strategies in major depression: focus on RNAi and ketamine.
Bortolozzi A; Celada P; Artigas F
Curr Pharm Des; 2014; 20(23):3848-60. PubMed ID: 24180396
[TBL] [Abstract][Full Text] [Related]
38. Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants.
Kadriu B; Greenwald M; Henter ID; Gilbert JR; Kraus C; Park LT; Zarate CA
Int J Neuropsychopharmacol; 2021 Jan; 24(1):8-21. PubMed ID: 33252694
[TBL] [Abstract][Full Text] [Related]
39. Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT
Sekssaoui M; Bockaert J; Marin P; Bécamel C
Neuropsychopharmacology; 2024 Mar; 49(4):747-756. PubMed ID: 38212441
[TBL] [Abstract][Full Text] [Related]
40. Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice.
Qu Y; Chang L; Ma L; Wan X; Hashimoto K
Pharmacol Biochem Behav; 2023 Jan; 222():173500. PubMed ID: 36476377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
